![]() |
||
|
Manufacturing - Butter/Milkfat - 2000 Modification of Milkfat to Improve Manufacturing Properties and Nutritional Quality - Edward DePeters, UC Davis Earlier work demonstrated that the diet of the cow can be altered to increase the monounsaturated fatty acid composition of milkfat and later triglyceride structure. Improving the nutritional value of milkfat places dairy products in a more favorable context to consumers. Altering the fatty acid composition of milkfat has improved the spreading characteristics of butter. Breed (genetics) was also found to affect the fatty acid composition of milkfat. Breed differences in oleic acid content were found. Milkfat of Jersey cows was lowest in C18:1 in milkfat while Brown Swiss cows had the highest and Holstein cows were in the mid range. These results could be related in part to the stearoyl CoA desaturase enzyme system that converts C18:0 to C18:1. Identifying animals with high activity of the stearoyl CoA desaturase gene will allow breeding programs on dairy farms that result in increased C18:1 in milkfat. Likewise, improving our knowledge of the factors controlling the activity of the stearoyl CoA desaturase enzymes will result in new management programs to enhance the C18:1 content of milkfat. Improving the monounsaturated fatty acid (C18:1) content of milkfat will benefit the sale of dairy products containing milkfat. It may also be possible to reduce other saturated fatty acids in milkfat, including palmitic (C16:0) and myristic (C14:0) acids, which are fatty acids associated with human health. Altering triglyceride structure through nutrition of the cow has implications for the use of milkfat in various manufactured products. Currently, postharvest techniques of triglyceride fractionation are used to modify the physiochemical properties of milkfat. However, if a portion of the necessary modifications can be accomplished by preharvest techniques, for example nutrition of the cow, more dramatic and economic changes can be accomplished in conjunction with postharvest techniques. Feeding an increasing amount of fat in the form of yellow grease to lactating cows of the Holstein, Jersey and Brown Swiss breed increased the C18:1 and C18:2 cis 9 trans 11 (CLA) composition of milkfat. Milkfat from Jersey cows was lower in C18:1 and CLA than milkfat from both Holstein and Brown Swiss cows. This difference is proposed to be due to differences in the stearoyl CoA desaturase activity in the mammary gland. In subsequent research, feeding highly saturated fat to lactating Holstein cows increased the C18:1 content of milkfat, but not the CLA content. Feeding an unsaturated fat source to lactating Holstein cows increased both the C18:1 and CLA content of milkfat. These changes alter the nutritional value and manufacturing properties of the milkfat. It will be possible in the future to identify cows genetically superior for producing milkfat higher in C18:1 content. Breeding and nutrition programs will be established to produce milk containing milkfat of desired fatty acid composition. To determine the effect of fatty acid composition of the diet on the CLA content of milkfat, special diets were fed to cows identified for polymorphism for the D9 desaturase (stearoyl CoA desaturase) gene. In the first study a highly saturated source of dietary fat was fed to the lactating dairy cows over a period of four months. If the rumen microbes are contributing to the CLA content of milkfat through the hydrogenation of unsaturated fatty acids, the CLA content of milkfat should not be affected by the feeding of a highly saturated fat source. Neither the amount of fat fed nor the D9 desaturase genotype of the cow affected the CLA content of milkfat. The CLA content of milkfat averaged 3.2, 2.8 and 3.2 mg/g of fat for AA, AB and BB genotypes. The trans 11 isomer of C18:1 was also not affected by diet or genotype. The trans 11 C18:1 content of milkfat was 2.4, 2.4 and 2.3 mg/g of fat for AA, AB and BB. We proposed that these would be the responses to feeding highly saturated fat to lactating cows differing in the D9 desaturase genotype. In the second study, the same cows from the first study were fed a diet containing a rich source of unsaturated fatty acids. Soybean oil was used because of its high C18:2 (linoleic acid) content. Biohydrogenation of unsaturated fatty acids in the rumen may contribute CLA, which can be incorporated into milkfat. Additionally, biohydro-genation of C18:2 can yield trans 11 C18:1. At the mammary gland, this trans fatty acid may be desaturated to CLA by the D9 desaturase enzyme. The CLA content of milkfat increased with the addition of soybean oil to the diet. However, the CLA content of milkfat was not different for D9 desaturase genotype. In a final study, a group of 27 lactating Holstein cows was fed the same diet, but cows were blocked into groups based on D9 desaturase genotype as well as milk production and parity. Changes in fatty acid composition for genotype were small. We are currently investigating whether or not polymorphism exists in the promoter region of the gene that would allow us to distinguish differences in fatty acid composition of cows related to the D9 desaturase gene. The findings have potential practical implications. The fatty acid composition of the dietary fat affects the fatty acid and CLA content of milkfat. Therefore, it is possible for dairy producers to feed diets that enhance the monounsaturated and CLA content of milkfat. Dairy products containing milkfat will have higher CLA content, which will improve the nutritional value of milkfat for human consumption. Ruminant products provide good sources of CLA while plant oils are poor sources of CLA. In addition, the CLA isomers in ruminant products source as milk and meat fats are the biologically active isomer. Research on modifying the CLA content of milkfat is continuing. A USDA grant was obtained by the University of Nevada at Reno and the University of California, Davis, to study the effects of nutrition on the CLA content of meat and milk and the role of CLA in human health. The funding support of the grant summarized in this report by the California Dairy Research Foundation positioned researchers at UC Davis to obtain USDA funding. This new project will provide further information for the dairy industry. We used biosilicates to modify the functional properties and quality of buttermilk. Biosilicate, also called diatomaceous earth, is a fine powder with particle sizes ranging from 5 to 50 mm in diameter. It is composed of almost pure silica. Currently, biosilicate is used in the food industry mainly as filtration aids for removal of particulates from juices, beer and wines. Biosilicate can be used in its natural state or synthetically modified to enhance desired characteristics. We worked with three commercially available synthetic biosilicates (calcium silicate, magnesium silicate and Hyflo). Calcium silicate and magnesium silicate are produced by the hydro-thermal reaction of natural biosilicate with hydrated lime or hydrated magnesia. Hyflo is a fused biosilicate designed to be a monodispersed substance. Buttermilk was treated at both benchtop and pilot plant levels. To gain an understanding of the functional properties of treated buttermilk, emulsions of 10 percent fat were made by homogenization of the treated buttermilk with a fat source. Buttermilk was treated with three types of biosilicates to understand the role of different types of biosilicates in this process. Additionally, three fat sources were used—butter, soybean oil and vegetable shortening—to determine if lipid type has an affect on the buttermilk’s functionality. This provides information useful to the incorporation of treated buttermilk in to a wide variety of food products. The buttermilk, recovered biosilicates and emulsions were subjected to a battery of tests to help determine what changes occurred during the process. The protein and lipid composition of the buttermilk and recovered biosilicates were measured to examine changes that might have occurred. The emulsions were characterized by evaluation of viscosity, foaming, creaming rate, particle size, protein composition and protein load of the fat globule membrane. Analysis of the treated buttermilk showed that little change occurred from the process (i.e., from a nutritional standpoint, the buttermilk remains unchanged by the process). However, when the treated buttermilk was used to make emulsions, many significant changes in functionality were found. For example, treatment with various types of biosilicates resulted in changes in viscosity, foam capacity and foam stability. Examination of the recovered biosilicates showed that the biosilicates did in fact adsorb different proteins and glycoproteins, which explains some of the differences seen in the emulsions. To gain a deeper understanding of the emulsions formed, we studied the fat globule membrane of the newly formed emulsion. SDS-PAGE revealed differences in the proteins present on the membranes of the various emulsion. Protein load of the fat globules was calculated revealing large variation in the amount of protein that adsorbed into the newly formed membrane. The general findings show that minor changes in buttermilk lead to significant changes in proteins on membrane surface, which in turn dramatically affect functionality of buttermilk The biosilicate’s ability to adsorb certain components from buttermilk and butteroil was also studied. Specifically, the absorptive capacity of the three types of biosilicates for free fatty acids from the an aqueous model system and from butter was evaluated. Gas chromatography was used to quantitate the levels of butyric acid both before and after treatment with biosilicates. These results were compared with sensory evaluation information. The biosilicates examined have the ability to decrease free fatty acid levels in dairy systems both with and without the presence of fat.Of the biosilicates compared, magnesium silicate was found to be the most effective in a fat-containing system, while calcium silicate is believed to be the most effective in a non-fat system. Applied to dairy products such as milk, cream, buttermilk or butter oil, this process has the potential to become a commercial method for standardizing and improving quality by reducing free fatty acids. Dairy products were analyzed and found to contain primarily the vitamin E isomer alpha tocopherol in levels in direct proportion to total fat and cholesterol. Hence the removal of fat to produce low-fat dairy products removes proportionately the tocopherols as well. Dietary experiments were conducted with hamsters to determine the effect of fat on absorption of different tocopherol isomers and carotenoids into blood lipoproteins. Tocopherols and carotenoids were well absorbed from both dietary fats with all of the fat-soluble nutrients appearing in the lipoproteins of the animals following their ingestion. However, the milkfat-fed animals compared to the corn-oil fed animals exhibited greater proportions of alpha tocopherol relative to gamma tocopherol even when both tocopherols were fed at the same level in the diets. Milk is a source of vitamin E in the diet primarily because the active vitamin E isomer alpha tocopherol is the major isomer in milkfat. Although milk does not contain high quantities of vitamin E, the presence of milkfat encourages the absorption of this and other fat-soluble nutrients. With the recognition that few foods are able to provide sufficient alpha tocopherol to meet recently revised dietary guidelines and the ability of milk to carry and deliver vitamin E successfully to tissues, the dairy industry should consider supplementing dairy products with alpha tocopherol to become the logical dietary carrier of this essential vitamin. Alpha tocopherol is well absorbed and delivered to circulating lipoproteins from a milkfat matrix. Removal of milkfat from dairy products removes the vitamin E as well as the fat. Therefore, the dairy industry should consider supplementing its products with alpha tocopherol and positioning itself as the dietary food of choice for this nutrient. This project has three sequential aims. First, we need to make a gene construct to express the gene in milk and produce transgenic mice carrying this construct. Once we have mice carrying the gene, we need to characterize desaturase expression in the mammary gland at the RNA and protein levels. Finally, once we have lines of transgenic mice to predict the level of expression in the human gene, we need to characterize the fatty acid composition of mouse milk and compare it to transgenic mouse milk. If we can show that the composition of fatty acids is significantly altered, then we could expect positive health benefits for humans if the same change was introduced into the mammary gland of a dairy cow. Given the expense of producing transgenic cows, it is logical to carry out the initial work in mice to demonstrate that we can significantly alter fat composition before undertaking the production of transgenic ruminants. To that end, two gene constructs were constructed and a total of 19 transgenic founder animals were produced. From these animals, 13 transgenic mouse lines have been established—one based on the goat b-casein promoter construct and the remainder on the cattle b-lactoglobulin promoter construct. Saturated fatty acids in the diet raise serum cholesterol concentrations and one-third of the saturated fatty acid in American diets comes from the consumption of dairy products. Milk has short-chain and saturated fatty acids. Many health recommendations have been made to reduce human consumption of saturated fatty acids. Thus, milk with an altered fatty acid composition would be of great benefit and value. It is clear that alterations in saturated content can be obtained nutritionally and that human consumption of such altered products can significantly alter cholesterol levels. The "ideal" nutritional milkfat, based on dietary recommendations, consist of approximately 25 percent saturated fatty acids, 75 percent monounsaturated fatty acids and 5 percent polyunsaturated fatty acids. Preliminary data collected on milk from four of the transgenic mouse lines suggests that the expression of the desaturase transgene in the mammary gland has resulted in significant alterations in the amount of one or more of the major saturated fatty acids (14:0, 16:0, and 18:0) in each line, as well as the amount of the derived monounsaturated fatty acid. Based on the preliminary data, the potential appears to exist, assuming appropriate levels of transgene expression are obtained, for significantly altering milk fatty acid composition |
||
© 2009 CDRF - Research photos courtesy of USDA Agriculture Research Service.